How to control pain in patients with pancreatic cancer?

Share This Post

Pancreatic cancer can invade and press nerves near the pancreas, which may cause abdominal or back pain in patients with pancreatic cancer. Pain specialists can help develop pain relief plans.

For most patients, morphine or similar drugs (opioids) can help control pain. But many people worry that these drugs will be addictive, but studies have shown that if patients take the doses prescribed by doctors, then the probability of patients being addicted to this drug is extremely low.

Analgesic drugs are best when taken regularly, but they are less effective if used only when the pain is severe. Several long-acting morphine and other opioids are in pill form and only need to be taken once or twice a day. There is also a long-acting drug fentanyl, which is used as a patch every 3 days. The common side effects of these drugs are nausea and drowsiness, which tend to improve over time. Constipation is a common side effect, and most patients need to take laxatives every day.

In addition, the doctor may block the nerves near the pancreas by using anesthetics or nerve-damaging drugs. This process is accomplished by passing the needle through the skin or using an endoscope (a long, soft tube that runs down the throat through the stomach). In addition, the use of chemotherapy and / or radiotherapy treatment can reduce pain by reducing the size of the tumor.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy